A carregar...
Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy
Histone deacetylase (HDAC) enzymes play a critical role in the epigenetic regulation of cellular functions and signaling pathways in many cancers. HDAC inhibitors (HDACi) have been validated for single use or in combination with other drugs in oncologic therapeutics. An even more novel combination t...
Na minha lista:
| Publicado no: | Oncolytic Virother |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918398/ https://ncbi.nlm.nih.gov/pubmed/27512681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OV.S66081 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|